New research paper: Navigating the computational landscape for drug repurposing.

Check out the latest study conducted by #REPO4EU researchers 💊 'Navigating the Computational Landscape for #DrugRepurposing'

Published by @annualreviews.bsky.social ➡️ annualreviews.org/content/jour...

@upm.es @neurologieessen.bsky.social @maastrichtu.bsky.social

#EUfunded #EU4Health #HaDEA

"Manhattan Projects for Preventive Medicine" - a brand new article from Network and Systems Medicine Journal from #REPO4EU on #ScienceOpen 💊 🆕

🖇️ #PreventiveMedicine #ChronicDisease #ManhattanProject

SMART: Systematic Model adequacy Assessment and Reporting Tool.

A team of #REPO4EU researchers from @maastrichtumc.bsky.social have developed a new tool to make decision models more accessible in early-stage or data-limited healthcare research.

But how will it benefit #DrugRepurposing researchers? Read the full story to find out 👉 repo4.eu/2025/08/26/r...

Driving the Future of Medicine: Submit Your Research to Drug Repurposing, the Official Journal of the REPO4EU Project - ScienceOpen Blog We are excited to invite submissions to Drug Repurposing, the official journal of the REPO4EU (European Platform for Evidence-Based Repurposing of Medicines) project. As an open access journal hosted ...

We're calling for papers! 🧬
Drug Repurposing, the official journal of #REPO4EU, is now open for submissions.

Open access, global visibility, and a top-tier editorial board.

🔗 Submit now: blog.scienceopen.com/2025/04/driv...

#DrugRepurposing #ScienceOpen

DrugRepoChatter: A Drug Repurposing Expert Chatbot Curated by the REPO4EU Consortium <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d1530720e392">The amount of scientific literature available is overwhelming, especially in fast-evolving ...

This is a cool article in the new @repo4eu.bsky.social journal Drug Repurposing and an ever cooler #AI tool: 'DrugRepoChatter: A #DrugRepurposing Expert Chatbot Curated by the #REPO4EU Consortium' drugrepocentral.scienceopen.com/hosted-docum...

Drug Repurposing bei seltenen Erkrankungen Wenn nur vergleichsweise wenige Patienten von einer Krankheit betroffen sind, entwickeln die Pharma-Unternehmen kaum Medikamente in diesem Bereich.

On #RareDiseaseDay, Prof. Kay Grünewald (@uni-hamburg.de) reflected on the power of #DrugRepurposing to advance treatments for #RareDiseases, highlighting the work of #REPO4EU & @remedi4all.bsky.social 💊

Listen to the interview (in German) on @ndr.de.web.brid.gy 👇
www.ndr.de/nachrichten/...

Experts from the #REPO4EU Consortium have joined forces to develop an AI tool that helps #DrugRepurposing researchers do literature review faster and more efficiently 💊 📝

Bioinformatician Fernando Delgado-Chaves from @cosybio-uhh.bsky.social explains how it works ⤵️
repo4.eu/2025/02/14/r...

DrugRepoChatter: A Drug Repurposing Expert Chatbot Curated by the REPO4EU Consortium <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d1530720e392">The amount of scientific literature available is overwhelming, especially in fast-evolving ...

New tools #AI tools: 'DrugRepoChatter: A #DrugRepurposing Expert Chatbot Curated by the #REPO4EU Consortium' published in the new journal Drug Repurposing. @repo4eu.bsky.social : drugrepocentral.scienceopen.com/hosted-docum...

Original post on fediscience.org

Just finished the final review with the EU Commission's #HADEA Project Officer and experts for our concluded #H2020 #drugrepurposing project, REPO-TRIAL (https://repo-trial.eu/ We have already made a smooth transition to the much larger #HorizonEurope follow-up project, #REPO4EU ( […]